Mouchamps E, Gaspard U. - La problématique du désir sexuel chez la femme ménopausée : une évaluation succincte. J Gynecol Obstet Biol Reprod, 1999, 28, 232-238.
Graziottin A. - Female sexual function and dysfunction: can the Cinderella of medicine turn into a princess? Climacteric, 2001, 4, 4-6.
Berman L, Berman J, Chhabra S, Goldstein I. - Novel approaches to female sexual dysfunction. Exp Opin Invest Drugs, 2001, 10, 85-95.
DeUgarte CA, Berman L, Berman J. - Female sexual dysfunction - from diagnosis to treatment. Sexuality, Reproduction and Menopause, 2004, 2, 139-145.
American Psychiatric Association. - DSM IV. Manuel diagnostique et statistique des troubles mentaux. Masson. Paris, 1995.
Derogatis L, Rust J, Golombok S, et al. - A patient based diary to measure sexual activity in menopausal women with HSDD. Presented at the International Society for the Study of Women's Sexual Health, October 28-31, 2004, Atlanta, Georgia.
Derogatis L, Rust J, Golombok S, et al. - Validation of the Profile of Female Sexual Function (PFSF) in Surgically and Naturaly Menopausal Women. J Sex Marital Therapy, 2004, 30, 25-36.
Mc Horney CA, Rust J, Golombok S, et al. - Profile of Female Sexual Function: a patient-based, international, psychometric instrument for the assessment of hypoactive sexual desire in oophorectomized women. Menopause, 2004, 11, 474-483.
Derogatis L, Rust J, Golombok S, et al. - A patient-generated, multinational inventory to measure distress associated with low desire. Presented at the International Society for the Study of Women's Sexual Health, October 28-31, 2004, Atlanta, Georgia.
Brill M. - Antidepressants and sexual dysfunction. Sexuality, Reproduction and Menopause, 2004, 2, 35-40.
The North American Menopause Society. - The role of testosterone therapy in postmenopausal women: Position statement of The North American Menopause Society. Menopause, 2005, 12, 497-511.
Bachmann G, Bancroft J, Braunstein G, et al. - Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril, 2002, 77, 660-665.
Gerber J, Johnson J, Bunn J, et al. - A longitudinal study of the effects of free testosterone and other psychosocial variables on sexual function during the natural traverse of menopause. Fertil Steril, 2005, 83, 643-648.
Davis S, Davison S, Donath S, Bell R. - Circulating androgen levels and self-reported sexual function in women. JAMA, 2005, 294, 91-96.
Shifren JL. - The role of androgens in female sexual dysfunction. Mayo Clin Proc, 2004, 79, S19-S24.
Wierman ME, Basson R, Davis SR, et al. - Androgen therapy in women: An endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2006, 91, 3697-3716.
Basson R, Leiblum S, Brotto L, et al. - Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision. J Psychosom Obstet Gynaecol, 2003, 24, 221-229.
Shifren JL, Braunstein GD, Simon JA, et al. - Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. New Engl J Med, 2000, 343, 682-688.
Buster JE, Kingsberg SA, Aguirre O, et al. - Testosterone patch for low sexual desire in surgically menopausal women. Obstet Gynecol, 2005, 105, 944-952.
Braunstein GD, Sundwall D, Katz M, et al. - Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women. Arch Intern Med, 2005, 165, 1582-1589.
Simon J, Braunstein G, Nachtigall L, et al. - Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab, 2005, 90, 5226-5233.
Shifren JL, Davis SR, Moreau M, et al. - Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the intimate NM1 study. Menopause, 2006, 13, 770-779.
Davis SR. - The effects of Tibolone on mood and libido. Menopause, 2002, 9, 162-170.
Chudakov B, Ben Zion I, Belmaker RH. - Transdermal testosterone gel application for hypoactive sexual desire disorder in premenopausal women: A controlled pilot study of the effects on the Arizona sexual experiences scale for females and sexual function questionnaire. J Sex Med, 2007, 4, 204-208.
Artl W. - Androgen therapy in women. Eur J Endocrinol. 2006, 154, 1-11.
Zang H, Sahlin L, Masironi B, et al. - Effects of testosterone treatment on endometrial proliferation in postmenopausal women. J Clin Endocrinol Metab, 2007, 10, 2006-2171.
Guzick DS. - Can postmenopausal women patch up their sex lives with testosterone ? Obstet Gynecol, 2005, 105, 938-940.
Kaaks R, Berrino F, Key T, Rinaldi S, et al. - Serum sex steroids in premenopausal women and breast cancer risk within European Prospective Investigation into Cancer and nutrition (EPIC). J Natl Cancer Inst, 2005, 97, 755-765.
Tamimi RM, Hankinson SE, Chez WY, et al. - Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Arch Intern Med, 2006, 166, 1483-1489.
Hofling M, Hirschberg AL, Skoog L, et al. - Testosterone inhibits estrogen/progestogen induced breast cell proliferation in postmenopausal women. Menopause, 2007, 14, 183-190.
Somboonporn W, Davis S. - Postmenopausal testoterone therapy and breast cancer risk. Maturitas, 2004, 49, 267-275.
Dimitrakakis C, Jones R, Liu A and Bondy C. - Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy. Menopause, 2004, 11, 531-535.
Burger H. - Editorial. Should testosterone be added to estrogen-progestin therapy for breast protection ? Menopause, 2007, 14, 159-162.
Recommandations proposées par un groupe d'experts (Belgian Menopause Society) concernant l'hormonothérapie après la ménopause. Gunaïkeia, 2007, 12, 21-23.
